机译:[11 sup> C] GF120918通过PET评价小鼠P-糖蛋白和乳腺癌抵抗蛋白相关的极限脑穿透
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan;
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan;
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan;
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan;
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan;
Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, 263-85;
Positron emission tomography (PET); P-glycoprotein (P-gp); Breast cancer resistance protein (BCRP); Carbon-11; GF120918; Elacridar;
机译:使用((11)C)GF120918通过PET在小鼠中评估与P-糖蛋白和乳腺癌抗性蛋白有关的有限脑渗透。
机译:使用(11C)GF120918(一种P-糖蛋白和乳腺癌抗性蛋白的双重放射性配体)对带有人结肠腺癌细胞的小鼠进行PET研究。
机译:P-糖蛋白(P-gp / Abcb1)和乳腺癌抗性蛋白(Bcrp / Abcg2)在限制厄洛替尼,黄酮吡啶酮和米托蒽醌限制脑部和睾丸渗透方面的动力学分析
机译:Stilbene类似物通过P-糖蛋白外排作为乳腺癌干细胞的抑制剂; 3D定量结构-活性关系研究(Stilbenes类似物对乳腺癌干细胞的抑制活性)
机译:GenX抑制Sprague-Dawley大鼠的P-糖蛋白和乳腺癌抗性蛋白转运活性及在血脑屏障的表达
机译:PET显像对乳腺癌抵抗蛋白和P-糖蛋白对Ko143组织分布和排泄的影响
机译:p-糖蛋白和乳腺癌抗性蛋白质:两个主要的运输工具在限制Topotecan的脑渗透时共同努力